^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
PGDx elio® plasma focus™ Dx

Company:
LabCorp
Type:
FDA Approved (PMA)
Related tests:

Details

Evidence
PGDx elio plasma focus Dx is the first and only FDA-authorized pan solid tumor liquid biopsy kitted solution...PGDx elio plasma focus Dx is a qualitative next-generation sequencing-based in vitro diagnostic device that uses targeted high throughput hybridization-based capture technology for the detection of single nucleotide variants (SNVs), insertions and deletions (indels) in 33 genes, copy number amplifications (CNAs) in five genes, and translocations in three genes.
Cancer:
Solid Tumor
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), ARID1A (AT-rich interaction domain 1A), ATM (ATM serine/threonine kinase), BRAF (B-raf proto-oncogene)
See More ...
Method:
Next Generation Sequencing
Approvals
Date
Cancer
Gene
Drug
By
04/25/25
FDA (PMA)